Global Leading Market Research Publisher QYResearch announces the release of its latest report “Traditional Chinese Medicine Intelligent Tongue Diagnosis Device – Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032″. Based on current situation and impact historical analysis (2021-2025) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global Traditional Chinese Medicine Intelligent Tongue Diagnosis Device market, including market size, share, demand, industry development status, and forecasts for the next few years.
For TCM practitioners, hospitals, and healthcare institutions, traditional tongue diagnosis is subjective, operator-dependent, and lacks standardization. The TCM intelligent tongue diagnosis device addresses this through AI-powered image analysis: high-precision image positioning, recognition, restoration, and automated classification using deep learning algorithms, integrating diagnosis, monitoring, and intervention for digestive system diseases (gastritis, ulcers, reflux). According to QYResearch’s updated model, the global market for Traditional Chinese Medicine Intelligent Tongue Diagnosis Device was estimated to be worth US$ 25.3 million in 2025 and is projected to reach US$ 33.83 million, growing at a CAGR of 4.3% from 2026 to 2032. In 2024, global Traditional Chinese Medicine Intelligent Tongue Diagnosis Device production reached approximately 2,680 units, with an average global market price of around US$ 9,028 per unit. The Traditional Chinese Medicine Intelligent Tongue Diagnosis Device is a comprehensive hardware and software product for TCM. It has obtained numerous software copyrights and patents and has been selected as a Ministry of Industry and Information Technology (MIIT) project. It features high-precision image positioning guidance and recognition, high-precision image restoration, and automated classification and sorting using image analysis algorithms. It can be widely used in advanced manufacturing and smart healthcare fields, including deep image processing and image recognition. This intelligent and convenient device, with room for upgrades, monitors vital signs, integrating diagnosis, monitoring, and intervention, providing users with the most convenient and practical mobile healthcare benefits. This product collects a large sample of tongue images, gastroscopy, and pathology data to establish a clinical big data collection platform for tongue image diagnosis of digestive system diseases. Using artificial intelligence image processing and auxiliary diagnosis algorithms, it explores the correlation between tongue images and common digestive system diseases, and develops a TCM tongue image automatic analysis and auxiliary diagnosis system for digestive system diseases.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/6095903/traditional-chinese-medicine-intelligent-tongue-diagnosis-device
1. Technical Architecture: Form Factors and Clinical Applications
TCM intelligent tongue diagnosis devices are segmented by form factor, determining deployment setting and portability:
| Form Factor | Dimensions | Weight | Target Setting | Tongue Image Capture | Price (USD) | Market Share (Units) |
|---|---|---|---|---|---|---|
| Floor-standing Type | 150cm H x 60cm W x 50cm D | 50-80 kg | Hospital TCM departments, large clinics | Automated positioning, standardized lighting | $10,000-15,000 | 40% |
| Countertop Type | 40cm H x 30cm W x 25cm D | 5-10 kg | Small clinics, teaching institutions, mobile health | Manual positioning, built-in lighting | $5,000-8,000 | 60% |
Key technical challenge – image standardization (lighting, color calibration, tongue positioning): Lighting conditions and tongue protrusion vary across devices and operators. Over the past six months, several advancements have emerged:
- West China Pitech (February 2026) introduced a floor-standing device with integrated D65 standard illuminant (color temperature 6500K, CRI >95) and automated tongue positioning (chin rest + forehead rest), eliminating operator variability in image capture.
- Moyowell (March 2026) commercialized a countertop device with smartphone integration (iOS/Android app) and cloud-based AI analysis, enabling remote tongue diagnosis for telemedicine (TCM consultation via video call).
- Beijing Bayes Yunzhen Information Technology (January 2026) launched a device with deep learning algorithm (ResNet-50 architecture) trained on 100,000+ tongue images correlated with gastroscopy findings, achieving 85% accuracy for chronic gastritis detection.
Industry insight – clinical validation: Correlation with gastroscopy (gold standard) is critical for regulatory approval (NMPA in China). Devices with published clinical studies (sensitivity >80%, specificity >80%) command premium pricing (20-30% higher). NMPA registration requires 3-5 years and $500k-1M investment.
2. Market Segmentation: Form Factor and Application
The Traditional Chinese Medicine Intelligent Tongue Diagnosis Device market is segmented as below:
Key Players: West China Pitech (China), Zhongke XinChuang (China), Moyowell (China), Shanghai National Group Health Technology (China), Beijing Bayes Yunzhen Information Technology (China), Hainda High-Tech (China), XINMAN (China)
Segment by Form Factor:
- Countertop Type – Largest segment (60% of 2024 units). Small clinics, teaching institutions, mobile health.
- Floor-standing Type – 40% of units. Hospital TCM departments, large clinics.
Segment by Application:
- Hospital – Largest segment (50% of revenue). TCM departments, gastroenterology clinics, health checkup centers.
- Traditional Chinese Medicine Clinic – 30% of revenue. Private TCM practices, community health centers.
- Teaching Institution – 10% of revenue. TCM universities, training centers.
- Others – Telemedicine, research institutions, mobile health screening (10% of revenue).
Typical user case – hospital gastroenterology clinic: A tertiary hospital in China (500 beds) installs a floor-standing TCM tongue diagnosis device (West China Pitech, $12,000) in the gastroenterology clinic. Patients with dyspepsia undergo tongue imaging before gastroscopy. AI algorithm predicts chronic gastritis probability (85% accuracy). Integration with hospital information system (HIS) enables data correlation. Annual throughput: 5,000 patients. Cost per patient: $2.40. Value: non-invasive screening reduces unnecessary gastroscopies (30% reduction). Annual savings: $150,000.
Exclusive observation – “digestive disease correlation” database: The largest clinical dataset (50,000+ tongue images correlated with gastroscopy and pathology) is owned by West China Hospital (Chengdu). Devices with access to this dataset (via partnership) have higher algorithm accuracy. Data access is a competitive moat.
3. Regional Dynamics and TCM Policy
| Region | Market Share (2025) | Key Drivers |
|---|---|---|
| Asia-Pacific | 85% | Largest TCM market (China, Japan, South Korea), government support (China MIIT projects), NMPA regulatory pathway |
| North America | 8% | Growing integrative medicine, acupuncture practices, Chinese diaspora |
| Europe | 5% | TCM acceptance (Germany, UK, France), research institutions |
| RoW | 2% | Emerging TCM adoption |
Exclusive observation – “MIIT project” endorsement: Selection as a Ministry of Industry and Information Technology (MIIT) project provides government funding and credibility. MIIT-approved devices have higher adoption in public hospitals. West China Pitech and Zhongke XinChuang have MIIT project status.
4. Competitive Landscape and Outlook
| Tier | Supplier | Key Strengths | Focus |
|---|---|---|---|
| 1 | Hospital-affiliated | West China Pitech (West China Hospital collaboration) | Largest clinical dataset (gastroscopy correlation), MIIT project, premium pricing |
| 1 | Technology innovators | Beijing Bayes Yunzhen (AI algorithms), Moyowell (mobile integration) | AI/cloud focus, telemedicine |
| 2 | Regional | Zhongke XinChuang, Shanghai National Group, Hainda High-Tech, XINMAN | Domestic market, cost-competitive |
Technology roadmap (2027-2030):
- Multimodal diagnosis integration – Tongue diagnosis + pulse diagnosis (sphygmometer) + facial diagnosis (AI) for comprehensive TCM assessment.
- Wearable tongue imaging – Smartphone attachment for home-based tongue monitoring (chronic disease management).
- Predictive analytics – Longitudinal tongue image analysis for early warning of digestive disease progression (gastric cancer risk prediction).
With 4.3% CAGR and 2,680 units produced in 2024 (projected 3,500+ by 2030), the TCM intelligent tongue diagnosis device market benefits from TCM modernization, AI healthcare adoption, and digestive disease screening. Risks include regulatory barriers (NMPA approval process), clinical validation requirements (expensive and time-consuming), competition from traditional TCM diagnosis (no capital cost), and reimbursement uncertainty (whether tongue diagnosis is covered by insurance).
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
